Manual of Clinical Anesthesiology
South Asian Edition of Manual of Clinical Anesthesiology, Second Edition
Monitoring Equipment and Procedures Subspecialty Anesthesia
twenty-two Author Acknowledgments
1 Anesthesiology and Person-Centered Anesthesia Practice
1) Empathy for the patient experience
a) Advice for new anesthesiologists from your future patient
b) Advice for new anesthesiologists from your future patient
2) Partnership with patients in perioperative medicine
d) Advice for new anesthesiologists from your future patient
e) Communication between patient and anesthesia provider.
Induction. Several communication strategies can enhance anesthesiologist-patient partnership during the induction period:
3) Sparking a joyful person-centered anesthesia practice
a) Listen to your patient
b) Engage in shared decision-making
c) Have considerate conversations
d) Maintain dignity of people
f) Demonstrate trustworthy behavior
REFERENCES 2 Learning and the Pursuit of Excellence
1) Approaching learning with purpose and structure
2) Sparking curiosity in the art and practice of anesthesiology
(2) Who can give feedback?
3) Cultivating joy in learning and practice
REFERENCES The Anesthetic Plan and Induction of Anesthesia wo
2) Preoperative assessment and optimization
d) Selection of anesthetic technique
(2) Monitored anesthesia care (MAC)
(3) General anesthesia (G A)
(4) Peripheral nerve block (P N B)
b) Selection of patient monitors
ii) Premedications prior to induction of G A
(g) Neuromuscular blocking agent
(i) Airway instrumentation
(3) Rapid sequence intubation (R S I)
iv) Inhalational induction
d) Maintenance of anesthetic plan
e) Emergence from anesthesia
4) Postoperative care plan
REFERENCES Preanesthesia Assessment
1) Overview: The A S A has published basic standards for a preanesthesia evaluation.
g) General examination may include the following:
4) Review any investigations that are available and decide whether additional testing is necessary.
6) Indications for additional information
7) Specific considerations
b) Prevention of pulmonary aspiration
8) Cardiac disease (Table 4-5)
10) ASA physical status classification
11) The Perioperative Surgical Home
References Intraoperative Management and Maintenance of Anesthesia
b) Several goals include:
3) Monitoring and maintenance of physiologic homeostasis
c) Fluid and blood products should be administered to maintain euvolemia and the blood's oxygen-carrying capacity.
CHAPTER SUMMARY FOR INTRAOPERATIVE MANAGEMENT AND MAINTENANCE OF ANESTHESIA
Emergence and Postoperative Issues in Anesthesia
2) Evaluation of the signs and stages of anesthesia
3) Preparation for emergence
4) Extubation criteria (Table 6-2)
5) Deep extubation (Fig. 6-1)
Seven) Postoperative considerations.
c) Agitation and emergence delirium (ED).
d) Inadequate postoperative analgesia
e) Hypothermia and shivering
f) Postoperative nausea and vomiting (P O N V)
g) Low urine output and acute kidney injury (A K I)
Positioning of the Surgical Patient
2) Factors affecting positioning (Table 7-1)
3) General positioning guidelines 15
4) Positioning guidelines
b) Common upper extremity injuries
c) Common lower extremity injuries
b) Postoperative blindness
7) Summary of perioperative neuropathy task force consensus
b) Upper extremity positioning
c) Lower extremity positioning
f) Postoperative assessment
CHAPTER SUMMARY FOR POSITIONING OF THE SURGICAL PATIENT
Hazards of the Operating Room
1) Occupational exposure to waste anesthetic gases (WAGs)
d) Line isolation systems (isolation transformer + line isolation
e) Ground-fault circuit interrupters, G F C I.
3) Substance use disorder, S U D
5) Blood-borne Pathogen Exposure
d) Treatment and management
e) Determine risk associated with exposure
g) Test the patient or source of exposure
h) Therapy and follow-up should be based on the current CDC recommendations
ii) Standard precautions established by CDC, previously "universal" precautions. CDC recommend
4) Carbon dioxide (C O 2)
5) Multiple expired gas analysis
e) The most commonly monitored leads are II and V5.
7) Arterial blood pressure, B P.
c) Automatic oscillometric
vii) Invasive BP monitoring
CHAPTER SUMMARY FOR STANDARD MONITORS
10 Pulse Oximetry Alison Brainard
2) How pulse oximetry works
3) Accuracy of the pulse oximeter
REFERENCES 11 Capnography Jacob Elliott Schaff · Jessica Spellman
a) Sidestream capnometers
b) Mainstream capnometers
3) Techniques of CO2 measurement
d) Colorimetric C O two analysis
4) Normal capnogram (Fig. 11-1)
5) Clinical uses of capnography
c) Noninvasive estimate of P a C O two
d) Detection of patient disease (Table 11-1)
e) Detection of problems with the anesthetic breathing system
6) Interpretation of abnormal capnograms (Fig. 11-2)
b) Obstruction to expiratory gas flow
d) Cardiogenic oscillations
g) Incompetent inspiratory valve
h) Esophageal intubation (Fig. 11-3)
REFERENCES Invasive Arterial Blood Pressure Monitoring zero
b) Advanced waveform analysis
c) Dampening of the arterial tracing
iv) Assessment of dampening
5) Complications of arterial cannulation (Table 12-2)
REFERENCES Central Venous Monitoring/ Pulmonary Artery Catheter
g) Verification of correct site prior to dilation
e) Bleeding and hematoma formation
5) CVP interpretation (Fig. 13-5)
c) Central venous saturation (ScvO2)
Pulmonary Artery Catheters
4) PAC Interpretation (Fig. 13-8)
REFERENCES Focused Transthoracic Echocardiography
One. F O C U S Definition
Five. Clinical integration
b) FoCUS for screening cardiovascular disease
d) FoCUS and cardiac arrest
e) Penetrating cardiac injury
f) Shock and hemodynamic instability
g) Estimating central venous pressure, diagnosing hypovolemia, and predicting fluid responsiveness
a) Competence in basic critical care echocardiography:
REFERENCES Point-of-Care Ultrasound
1) Overview (Table 15-1):
2) Pulmonary: lung ultrasound (L U S)
b) How to perform basic examination:
ii) Motion mode (M-mode) findings
d) Assessment via BLUE protocol
3) Pulmonary: diaphragmatic ultrasound
b) How to perform basic diaphragmatic examination:
4) Abdominal and pelvic: gastric ultrasound
b) How to perform basic examination:
c) The type of gastric content present can be differentiated based on sonographic appearance.
e) Qualitative assessment:
5) Abdominal and pelvic: focused assessment with sonography for trauma, F A S T, Figs. 15-10 and 15-11.
b) How to perform basic examination:
b) How to perform basic examination:
e) Evaluation of vocal cord mobility can help diagnose postoperative etiology of stridor.
7) Vascular: deep venous thrombosis (DVT) ultrasound of lower extremity
b) How to perform basic examination:
16 Neurophysiologic Monitoring Shilpa Rao
1) Overview of neurophysiologic monitoring in anesthesia
b) Somatosensory evoked potentials (S S E Ps)
c) Brainstem auditory evoked potentials (B A E Ps)
d) Motor evoked potentials (M E P)
e) Electroencephalography (EEG)
3) Intraoperative awareness
b) Incidence and risk factors for intraoperative awareness
c) Detecting episodes of intraoperative awareness
4) Prevention or vigilance for detecting intraoperative awareness
b) Monitor processed EEG signals
i) Depth-of-anesthesia monitors
ii) Measurement errors and artifacts associated with depth-of-anesthesia monitors
ii) Using processed E E G as a depth-of-anesthesia monitor
iv) Postoperative outcomes
a) The high-pressure system
b) The low-pressure system
2) The high-pressure system
i) Central or pipeline supply
b) Pneumatic and electronic alarm devices
d) Oxygen pressure failure devices
ii) Types of circle systems
i) Active scavenging systems
ii) Passive scavenging system
6) Preanesthesia machine checkout
Anesthesia Breathing Circuits
2) Nonrebreathing systems—Mapleson circuits (Fig. 18-1)
(4) Controlled ventilation
ii) Lack system (coaxial Mapleson A)
ii) Mapleson B and C systems
(3) Spontaneous ventilation
v) Bain system (coaxial Mapleson D)
(a) Spontaneous ventilation
(b) Controlled ventilation
vi) Mapleson E and F systems
(5) Spontaneous ventilation
(c) Mechanical ventilation
(ix) Use of low flows in the circle system
(4) Interactions with anesthetic agents
(b) Other breakdown compounds
Chapter summary for anesthesia breathing circuits
1) Indications for mechanical ventilation
iv) Anatomic causes of ventilatory failure
v) Disorders of the pleura
vii) Gas exchange abnormalities can cause significant ventilatory failure.
c) Failure to oxygenate (hypoxic respiratory failure)
(2) Ventilation/perfusion (V/Q) mismatching
(i) Increased anatomic dead space
(ii) Pathologic dead space
three)Modes ofventilation (Figpoint one nine-one)
b) Noninvasive positive-pressure ventilation
6) Decreased incidence of nosocomial pneumonias
c) Invasive positive-pressure ventilation (IPPv)
ii) Indications for I P P V
(e) Assist-controlled volume, A C V-cycled ventilation
(iv) Disadvantage of I M V
(2) Pressure-cycled ventilation, P C V
(c) Disadvantages of P C V
(3) Pressure-regulated volume control ventilation, P R V C (Fig. 19-2)
(4) Pressure support ventilation, P S V (Fig. 19-3)
(c) Pressure support settings
(iii) Contraindication to P S V
(5) Airway pressure release ventilation, A P R V (Fig. 19-4)
b) Fraction of inspired oxygen, F i O 2
h) Positive end-expiratory pressure (PEEP)
d) Minimal sedation/anxiolysis
e) Moderate sedation/analgesia (conscious sedation)
f) Deep sedation/analgesia
6) Medications used for patients requiring mechanical ventilation
References Endotracheal Intubation
e) Alternatives to D L for endotracheal intubation might be considered in certain circumstances such as:
3) Preoperative airway assessment (Tables 20-1 and 20-2, Fig. 20-1)
4) Equipment for endotracheal intubation
iv) Head-elevated laryngoscopy position (H E L P)
V) Manual in-line stabilization for cervical spine trauma
6) Performing D L for orotracheal intubation
b) Place patient in proper "sniffing" or "HELP" (head-elevated laryngoscopy position) positions (obese patients).
7) Technique for nasotracheal intubation
d) The ETT position in the trachea will change with head motion and should be verified after repositioning the patient.
c) Aspiration of gastric contents
d) Endobronchial intubation
f) Compression of the tracheal wall may be caused by overinflation of the cuff.
CHAPTER SUMMARY FOR ENDOTRACHEAL INTUBATION Difficult Airway Management
b) Incidence of difficult airway and management outcomes (Table 21-1)
2) Approach to the difficult airway
b) Predicting difficult airway
American Society of Anesthesiologists Difficult Airway Algorithm
d) Deciding on awake versus asleep airway management
ii) Avoid direct laryngoscopy.
ii) Perform direct laryngoscopy.
iv) Use of neuromuscular blockade
3) Specialized airway devices and techniques
i) Solid or hollow semimalleable stylets
b) Supraglottic airway devices in difficult airway management i) General advantages
iv) Intubating LMA (I L M A, LMA-Fastrach)
v) The LMA-ProSeal and the LMA-Supreme
vii) Esophageal tracheal airway (Combitube)
(5) Placement of Combitube device
c) Video laryngoscopic techniques
ii) Predictors of failure
iii) Types of video laryngoscopes (V Ls)
iv) Proper use of video laryngoscopes
(v) Steering versus channeled V L
Scalpel-bougie technique for emergency front of neck access (FONA), Chapter 166
CHAPTER SUMMARY FOR DIFFICULT AIRWAY MANAGEMENT 22 Supraglottic Airway Devices Brian J. Egan
1) Description of different types of laryngeal mask airways, LMAs
e) Intubating LMA (Fastrach) and LMA C-trach
f) Other supraglottic airway devices
ii) Evaluation of new devices
iii) Choosing from among competing devices
2) Indications for supraglottic airway device use
c) Absolute and relative contraindications
3) Advantages of supraglottic airway devices
4) Disadvantages of supraglottic airway devices
c) Adequate function of the LMA is dependent on appropriate position in the hypopharynx.
d) Reported rare, but severe, neurovascular complications due to trauma secondary to LMA use include:
5) Placement of an LMA—standard technique
b) Preparation of the patient
g) Emergence and removal of LMA
h) Complications associated with supraglottic airway device use
i) Other uses for supraglottic airway devices
Chapter summary for supraglottic airway devices
23 Fiberoptic Intubation, Adam W. Baca
One) Indications for fiberoptic intubation, F O I. One.
Two) Relative contraindications to fiberoptic intubation.
Three) Preparation for fiberoptic intubation.
b) Preparation and inspection of the fiberoptic scope
4) Operation of a fiberoptic scope
5) Preparation of the patient for awake fiberoptic intubation
d) Apply anesthesia to the airway.
ii) Superior laryngeal nerve block
iii) Transtracheal nerve block
g) Oxygenation and suction
6) Performing fiberoptic intubation 6
h) Insert the distal tip of the scope in the middle of the patient's mouth or in the nostril (if using nasal approach).
7) Difficulties and troubleshooting
b) Inability to advance E T T into the trachea over F O B
c) Inability to remove F O B
Chapter summary for fiberoptic laryngoscopy
2) Drug administration (Table 24-2)
5) Transport across membranes
6) Drug metabolism and elimination
7) Binding of drugs to plasma proteins
8) Drug-drug interactions (D D Is)
d) With respect to the cytochrome P450 2D6 enzyme, there are slow and fast metabolizers.
10) Pediatric pharmacology
11) Geriatric pharmacology
12) Pharmacology of pregnant patients
2) Structure-activity relationships
3) Types of local anesthetics
6) Adverse effects/toxicity (Table 25-2)
b) Transient neurologic symptoms
REFERENCES Neuromuscular Blockade and Anticholinesterases
i) Depolarizing muscle relaxants
ii) Nondepolarizing muscle relaxants
2) Monitoring neuromuscular blockade
iv) Posttetanic potentiation
ii) Abnormal pseudocholinesterase
iii) Nondepolarizing muscle relaxants
b) Nondepolarizing muscle relaxants
b) Muscle relaxation to facilitate surgery (i.e., abdominal surgery).
6) Adverse effects/toxicity
b) Depolarizing muscle relaxants
ii) Increased intraocular pressure (IP)
iii) Increased intracranial pressure
iv) Increased intragastric pressure
c) Persistent neuromuscular blockade
7) Drug interactions, medical conditions, and function of N M B agents
Anticholinesterases and Reversal of Neuromuscular Blockade 1) Mechanism of action
2) Clinical uses and common agents
4) Reversal of neuromuscular blockade
5) Adverse effects/toxicity
e) Organophosphate poisoning
6) Anticholinergic medications used with anticholinesterases
REFERENCES Benzodiazepines
b) Structure/activity relationships
3) Special considerations
5) Adverse effects/toxicity
Chapter summary for benzodiazepines
Opioid agonists and antagonists Daniel S. Orlovich
2) Structure/activity relationships
3) Administration of opioids
b) Parenteral administration
c) Neuraxial Administration
v) Effects of neuraxial opioids
4) Special considerations and drug interactions
6) Adverse effects/toxicity
g) Skeletal muscle rigidity
c) Side effects of naloxone
REFERENCES Nonsteroidal Anti-inflammatory Drugs and Acetaminophen
3) Structure-activity relationships
5) Special considerations
six) Clinical uses one-{three
7) Adverse effects/toxicity (Table 29-1)
References Intravenous Induction Agents
d) Effects on major organ systems
ii) Cardiovascular system
d) Effects on major organ systems
ii) Cardiovascular system
d) Effects on major organ systems
ii) Cardiovascular system
a) Ketamine is a water-soluble compound with a pKa of 7.5. It is structurally related to phencyclidine.
d) Effects on major organ systems
ii) Cardiovascular system
d) Effects on major organ systems
ii) Cardiovascular system
Inhaled Anesthetic Agents
iv) Factors affecting delivery, input
(b) Factors affecting uptake
iv) Alveolar-venous partial pressure difference, A-V D
c) Elimination of inhaled anesthetics
3) Minimum alveolar concentration (MAC) (Table 31-1)
e) Factors affecting MAC (Table 31-2)
ii) Cerebral metabolic rate of oxygen (CMRO2)
b) Cardiovascular effects (Table 31-3; Figs. 31-3 and 31-4)
ii) Myocardial contractility
ii) Systemic vascular resistance
c) Ventilatory effects of inhaled anesthetics (Fig. 31-5)
d) Pulmonary vascular resistance (P V R)
5) Inhaled agents in clinical use
CHAPTER SUMMARY FOR INHALED ANESTHETICS Adrenergic Agents
1) Sympathetic nervous system
b) Adrenergic antagonists/sympatholytics
3) Structure/activity relationships
b) Adrenergic antagonists
5) Adverse effects—generally dose-dependent and tend to reflect response exceeding clinically desired magnitude.
6) Clinical uses a) Agonists
7) Perioperative beta-blockade
CHAPTER SUMMARY FOR ADRENERGIC AGENTS
Perioperative Corticosteroids
1) Endogenous glucocorticoids
two) Adrenal insuffi ciency
3) Perioperative steroid replacement
4) Other indications for perioperative corticosteroids
b) Anti-inflammatory properties
c) Reduction of postoperative pain and opioid consumption
d) Prolongation of the effect of regional anesthesia
5) Contraindications to perioperative corticosteroids
REFERENCES Antimicrobials
1) Choice of antimicrobial agent
2) Type of surgical procedure
b) Clean-contaminated surgical wounds
c) Contaminated surgical wounds
d) Dirty or infected surgical wounds
e) Infective endocarditis, I E, prophylaxis
3) Timing of administration
4) Interactions with anesthetic agents
5) Adverse reactions to antimicrobials
c) Stevens-Johnson syndrome
CHAPTER SUMMARY FOR ANTIMICROBIAL MEDICATIONS
2) Anticoagulant medications (Table 35-1)
vii) Considerations for surgery/anesthesia
b) Low molecular weight heparin, L M W H
Five) Considerations for surgery/anesthesia
D) Direct oral anticoagulants, D O A Cs
Eight) Perioperative implications
E) Thrombolytic medications
f) Glycoprotein IIb/IIIa inhibitors
v) Considerations for surgery/anesthesia
iv) Considerations for surgery/anesthesia
2) Procoagulant medications (Table 35-3)
b) Factor eight concentrate
d) Prothrombin Complex Concentrate (P C C)
g) Desmopressin (D D A V P)
CHAPTER SUMMARY FOR HEMATOLOGIC AGENTS
SECTION V. INTRAOPERATIVE FLUID MANAGEMENT AND BLOOD COMPONENT THERAPY
1) Determinants of O two delivery to tissue
3) Classical calculation of fluid requirements
ii) Lactated Ringer's (L R)
ii) Balanced crystalloids (Normosol, Plasma-Lyte)
iv)Replacement of intravascular volume with crystalloid
b)Additional forms of crystalloid are available and have a diverse array of uses.
iii) Hypertonic 3% or 7.5% saline
iv) Highly concentrated 23.4% sodium chloride
d) Rational use of crystalloids and colloids
6) Pearls and pitfalls for select surgical populations
c) Cerebral edema and/or intracranial neurosurgical patients
d) Congestive heart failure (C H F)
e) Acute respiratory distress syndrome (A R D S)
h) Liver failure/hepatic transplantation
k) Laparoscopic gastric bypass surgery
REFERENCES Water, Electrolyte, and Acid-Base Disturbances
1) Overview of water, electrolyte, and acid-base disturbances
iv) Impact on enzymatic function
v) Impact on work of breathing
iv) Preoperative assessment.
3) Electrolyte disturbances
ii) Hyponatremia. Sodium less than 135 milliequivalents per liter
ii) Hypokalemia. K less than 3.6 milliequivalents per liter
ii) Hypophosphatemia: phosphorus less than 2.5 milligrams per deciliter
4) Acid-base disturbances
c) Assessing adequacy of ventilation
d) Assessing adequacy of oxygenation
Identify if a Mixed Acid-Base Condition Is Present
v) Renal etiology acidosis
REFERENCES Blood Component Therapy
1) Pretransfusion testing
e) Autologous blood donation
f) Directed donor blood donation
2) Packed red blood cells (P R B Cs)
c) P R B C transfusion parameters
3) Plasma (fresh frozen plasma [F F P])
6) Complications of transfusion
b) Acute hemolytic reaction
c) Delayed hemolytic reaction
d) Transfusion-related acute lung injury (T R A L I)
Alternatives to Blood Product Replacement
c) Patient refusal of blood products
2) Maintenance of normovolemia
3) Intraoperative cell salvage ("cell saver")
b) Indications for intraoperative cell salvage
ii) Potential complications
4) Acute normovolemic hemodilution (A N H)
c) Candidates for this procedure include the following:
5) Pharmacologic alternatives
b) Recombinant activated factor VII (rFVIIa)
c) Fibrinogen concentrates
6) Management strategies for patients who decline blood transfusion
b) Minimize oxygen consumption
c) Maximize oxygen delivery
7) The Jehovah's Witness (J W)
b) Preoperative informed consent
c) Alternative techniques and the J W patient (Table 39-1)
REFERENCES Massive Transfusion and Resuscitation
2) Causes and triggers (Table 40-1)
i) Assessment of blood consumption (A B C)
ii) Massive transfusion score (M T S)
3) Management goals in massive hemorrhage
ii) Intra-arterial blood pressure monitoring
vi) Temperature monitoring
vii) Airway management and maintenance
c) Maintenance of adequate perfusion
4) Mobilization of resources
5 Massive transfusion protocol/guideline 8
6) Blood product replacement specific to massive transfusion a) Packed red blood cells (p R B C)
b) Plasma (e.g., fresh frozen plasma [F F P])
d) Blood product ratios for massive transfusion
7) Recombinant coagulation factors and hemostatic agents
8) Complications of massive transfusion
g) Dilutional coagulopathy
h) Decreased 2,3-diphosphoglycerate
i) Disruptions in acid-base balance
1) Indications and contraindications
ii) Relative contraindications
b) Potential anatomical paths for the spinal needle
b) Determinants of block duration
c) Spinal needle and introducer
b) Positioning and preparation
c) Identification of surface anatomy
iv) Blood in the spinal needle
6) Risks and complications
b) Hypotension is a frequently encountered physiologic effect of spinal anesthesia.
c) Bradycardia may result from blockade of T1-T4 sympathetic cardioaccelerator fibers and decreased venous return.
d) Postdural puncture headache (PDPH)
f) Transient neurologic symptoms (TNS)
g) Spinal or epidural hematoma is extremely rare but often
h) Persistent neuropathy is extremely rare.
REFERENCES Epidural and Combined Spinal Epidural (CSE) Anesthesia
Epidural Anesthesia and Analgesia
ii) Relative contraindications
b) Determinants of block duration
c) Epidural needle and catheter
b) Positioning and preparation
c) Identification of surface anatomy
e) Median or midline approach
Combined Spinal Epidural, C S E
b) Operative procedure of uncertain duration
b) Difficulty threading the catheter
d) Nonspecific or nonconvincing loss of resistance
e) Failure of spinal portion of CSE (Fig. 42-2)
f) Failure of epidural portion of CSE
4) Risks and complications
c) Unilateral epidural anesthesia
e) Intravascular injection of local anesthetics
f) Respiratory depression
j) Persistent neurologic symptoms (see Chapter 41, Spinal Anesthesia, for more information)
REFERENCES Postdural Puncture Headache and Epidural Blood Patch
3) Incidence of headache with dural puncture depends on several variables
d) Patient characteristics
5) Differential diagnosis
g) Venous sinus thrombosis
6) Conservative treatment
d) Sphenopalatine ganglion blocks
7 Natural course of P D P H
d) EBP through an epidural catheter
9) Contraindications to EBP
CHAPTER SUMMARY FOR P D P H AND EPIDURAL BLOOD PATCH
Overview of Single-Injection and Continuous Peripheral Nerve Blocks
1) Basics of peripheral nerve blocks
b) Local anesthetics and additives (Table 44-1)
2) Benefits and indications
3) Risks and contraindications
b) Absolute contraindications
c) Relative contraindications
d) Minimizing neurologic injury
e) Minimizing the risk of bleeding
g) Systemic toxicity from local anesthetics
h) Risks specific to CPNB
5) Monitoring and positioning
6) Nerve localization techniques
b) Nerve stimulation technique
ii) CPNB using nerve stimulation
(c) Ultrasound-guided technique (Fig. 44-8)
C P N B local anesthetic infusion
Chapter summary for peripheral nerve block overview
Part A: Vascular Diseases. Primary Hypertension and Anesthetic Considerations
c. Risk factors (Fig. 45-1; Table 45-2)
a. Hypertensive urgency and emergency
b. Perioperative considerations for uncontrolled H T N
d) Perioperative considerations for patients with end-organ damage
3) Treatment and management
4) Anesthetic management of the patient with H T N
b) Intraoperative management
ii) Intraoperative hemodynamic management
(4) Cerebral autoregulation
5) Postoperative management
b) Adequate management of postoperative pain
REFERENCES Peripheral Vascular Disease
3) Risk factors for atherosclerosis
b) Peripheral vascular disease of lower extremities
6) Medical management of P V D
d) Blood pressure control
g) Phosphodiesterase inhibitors
7) Surgical management of chronic limb ischemia
c) Management of acute limb ischemia
8) Anesthetic management of peripheral vascular disease
i) Preoperative considerations
(4) Preoperative risk assessment
(5) Cardiac evaluation and optimization
b) Cardiac intervention prior to surgery
c) Percutaneous coronary intervention
10) Intraoperative management
11) Anesthetic considerations for carotid endarterectomy, CEA.
b) Intraoperative monitoring.
(8) Stump pressure measurement
c) Choice of anesthetic for C E A (regional or general anesthesia)
d) Anesthesia for carotid stenting
e) Postoperative complications
Deep Vein Thrombosis and Pulmonary Embolism
2) Physiological impact of P E
b) Intraoperative presentation of pulmonary embolism
c) Diagnosis is difficult to establish on clinical presentations alone.
f) CT pulmonary angiogram:
h) Magnetic resonance (MR) contrast-enhanced imaging
i) Transesophageal echocardiography
6) Decision tree for D V T slash P E
i) Anticoagulation: three main strategies
iii) Pulmonary embolectomy
iv) Inferior vena cava (I V C) filter
f Routine perioperative prophylaxis
REFERENCES Part B: Immunology and Infectious Diseases. Pulmonary Hypertension and Perioperative Management Strategies
5) Perioperative assessment
d) Management of PAH medication.
6) Intraoperative management
b) Nonimmunologic reactions (formerly anaphylactoid)
2) Agents responsible for Type One hypersensitivity reactions
c) Allergic reactions to local anesthetics
3) Clinical manifestations
4) Treatment of anaphylaxis (Table 49-1)
i) Airway and ventilation
ii) Secondary support measures
REFERENCES Human Immunodeficiency Virus
b) Acquired immunodeficiency syndrome, A I D S
3) Clinical manifestations
five) Anesthetic implications
REFERENCES Part C: Respiratory Diseases Chronic Obstructive Pulmonary Diseases
6) Pulmonary function tests (PFTs) (Fig. 51-1)
8) Preoperative considerations
9) Intraoperative considerations
10) Postoperative considerations
REFERENCES Asthma and Reactive Airway Disease
f) Mechanical irritation such as intubation
5) Severity scoring (Table 52-1)
7) Treatments (Table 52-3)
c) Leukotriene-modifying drugs
d) Inhaled corticosteroids (I C S)
f) Cromolyn sodium and nedocromil sodium
8) Preoperative management
e) Ascertain the need for steroid therapy
9) Intraoperative management
c) Warm and humidify gases to avoid tracheal irritation
10) Ventilatory management for asthma
11) Postoperative management
(8) Postoperative pain control
12) Less commonly used treatments
REFERENCES Restrictive Lung Disease
one) Definition and diagnosis
5) Management of restrictive lung disease
6) Anesthetic considerations
b) Intraoperative considerations
c) Postoperative considerations (Tables 53-2 and 53-3)
REFERENCES Obstructive Sleep Apnea
4) Preoperative management for O S A patients
5) Intraoperative management
6) Postoperative management
REFERENCES Part D: Diseases of the Nervous System. Anesthesia and Diseases of the Nervous System.
c) Amyotrophic lateral sclerosis (A L S), spinal muscle atrophy (S M A)
d) Duchenne muscular dystrophy, D M D, Becker muscular
iii) Maintenance and emergence
iv) Postoperative considerations
b) GBS: Acute infl ammatory demyelinating polyneuropathy (AIDP)
ii) Maintenance/emergence
3) Central demyelinating diseases: multiple sclerosis
b) Treatment includes the following:
iii) Maintenance/emergence
b) Neurologic Lyme disease (neuroborreliosis)
iii) Maintenance/emergence
iv) Postoperative considerations
5) Cerebral disease: Seizure Disorder
b) Pro- and anticonvulsant effects of anesthetic drugs
c) Anesthetic management of the patient for intracranial resection of seizure focus
d) Anesthetic management of the epileptic patient undergoing nonepilepsy surgery
e) Anesthetic management of the epileptic patient in status epilepticus
a) Ischemic vascular disease/cerebrovascular accident (CVA)
c) Anesthetic implications
(1) Preoperative considerations
(2) Intraoperative management
(3) Emergence/postoperative management:
7) Cerebellar and basal ganglia diseases: dementia and cognitive decline
ii) Maintenance/emergence
8) Cerebellar and basal ganglia diseases: Parkinson disease
ii) Maintenance/emergence
iv) Postoperative considerations
10) Summary considerations
Part E: Diseases of the Gastrointestinal and Urologic Systems. Diseases of the Liver
1) Functional hepatic anatomy and circulation
b) Carbohydrate metabolism
3) Endocrine functions of the liver
c) Drug metabolism is governed by three hepatic reactions.
6) Hepatic pathophysiology
d) Cholestatic liver disease
7) Perioperative risk assessment in patients with cirrhosis
b) The model for end-stage liver disease (M E L D) and M E L D-Na (Table 56-2)
8) Physiologic derangements of cirrhosis (Table 56-3)
f) Hematologic dysfunction
g) Metabolic abnormalities
9) Anesthetic implications of liver disease
B. Determine the type and severity of liver disease.
G. Operating room preparations
10. Intraoperative considerations
B. Drug selection and dosing
ii) Neuromuscular blocking agents (N M Bs)
iv) Other commonly used medications
(3) Intravascular volume status
c) Postoperative considerations
REFERENCES Diseases of the Gastrointestinal System
iv) Pharmacologic treatment
v) Perioperative considerations
(2) Intraoperative considerations
(3) Postoperative considerations
(d) Surgical treatment (including banding)
(e) Esophageal perforation
(iv) Perioperative considerations
iii) Perioperative considerations
ii) Acute bleeding ulcers
(2) Intraoperative considerations
3) Small intestinal diseases
ii) Anesthetic management of patients with IBD
(2) Intraoperative considerations
iii) Perioperative considerations
(2) Intraoperative considerations
d) Small bowel obstruction
ii) Perioperative considerations
4) Large intestinal diseases
ii) Perioperative considerations
iii) Perioperative considerations
iii) Perioperative considerations
ii) Perioperative considerations
iv) Perioperative considerations
ii) Perioperative considerations
iii) Perioperative considerations
iv) Perioperative considerations
b) Primary sclerosing cholangitis (P S C)
ii) Perioperative considerations
c) Primary biliary cirrhosis/primary biliary cholangitis (P B C)
iv) Perioperative considerations
CHAPTER SUMMARY FOR DISEASES OF THE G I SYSTEM
REFERENCES Kidney Disease
ii) Renal, acute tubular necrosis
5) Chronic kidney disease, C K D, (Table 58-4)
ii) Electrolyte disturbances (Table 58-5) iii) Cardiovascular
6) Anesthetic considerations
i) If patient is not on H D
b) Intraoperative considerations
ii) Maintenance of anesthesia
c) Postoperative considerations
Part F: Endocrine Diseases. Diabetes Mellitus.
d) Gestational diabetes mellitus (G D M).
3) Long-term complications from poorly controlled diabetes.
d) Delayed gastric emptying
6) Hyperosmolar, hyperglycemic nonketotic syndrome (HHNS)
7) Perioperative insulin management
b) Goal is to maintain a blood glucose (B G) level less than 180 milligrams per deciliter without causing hypoglycemia.
8) Perioperative approach to the diabetic patient
b) Intraoperative considerations
c) Postoperative considerations
References Thyroid Disease
d) Signs and symptoms (Table 60-1)
g) Preoperative anesthesia evaluation
Five. Perioperative testing.
Six. Preoperative medications
H. Intraoperative treatment
v) Postoperative treatment
vi) Treatment and resuscitation
b) Primary hypothyroidism
c) Secondary hypothyroidism (pituitary)
d) Tertiary hypothyroidism (hypothalamic)
h) Associated findings in untreated hypothyroidism
j) Preoperative anesthesia evaluation
vi) Preoperative medications
k) Intraoperative treatment
I) Postoperative treatment
g) Treatment and resuscitation
5) Complications after thyroid surgery
b) Recurrent laryngeal nerve damage
REFERENCES Adrenal Disorders
ii) Divisions of the adrenal glands
b) Disorders of hyperadrenalism or hypoadrenalism (Table 61-1)
v) Perioperative management
vi) Intraoperative considerations
vii) Postoperative considerations
b) Adrenal pathology with increased aldosterone production
c) Adrenal pathology with increased cortisol production (Cushing syndrome)
a) Anterior pituitary (adenohypophysis)
4) Hypersecretory disorders of concern for anesthesiologists:
5) Pituitary surgery and anesthetic considerations
b) Preoperative considerations
c) Intraoperative considerations
iv) Intraoperative hypotension
1) Anatomy/normal function of the parathyroid glands
2) Disorders of the parathyroid glands
iii) Diagnosis of hyperparathyroidism
iv) Clinical manifestations of hypercalcemia
v) Medical treatment of hypercalcemia
vi) Surgical treatment for primary hyperparathyroidism
(3) Open neck exploration
vii) Anesthetic management of patient with primary hyperparathyroidism
ii) Clinical manifestations of hypocalcemia
(5) Treatment of hypocalcemia
REFERENCES Obesity Amanda Kirzner- Andrea J. Traynor
c) Coronary artery disease
d) Obstructive sleep apnea (OSA)
e) Gastroesophageal reflux disease
g) Thromboembolic disease
3) Physiologic changes, Table 64-2.
b) Increased blood flow to adipose tissues
d) Gastrointestinal, see Table 64-2.
4) The perioperative approach to the obese patient
ii) Preoperative assessment
c) Preparing the OR for a morbidly obese patient
d) Intraoperative management
iii) Aspiration precautions
5) Postoperative pain management
b) Sensitivity to opioid medications
CHAPTER SUMMARY FOR OBESITY
Part G: Hematology and Oncology Red Blood Cell Diseases
2) The oxyhemoglobin dissociation curve
c) Hematopoietic input deficiencies
d) Peripheral R B C destruction
e) Defects in R B C membrane proteins or components
4) Physiologic changes associated with anemia
b) Acute anemia (Table 65-1)
c) Chronic anemia (Table 65-1)
6) Perioperative approach to the patient with anemia
c) Laboratory and other studies
d) Intraoperative considerations
e) Postoperative considerations
7) Perioperative considerations
b) Intraoperative concerns
c) Postoperative concerns
Variant sickle cell syndromes
4) Perioperative considerations
b) Intraoperative and postoperative considerations
REFERENCES Coagulopathies
c) Acquired coagulation factor defects
d) Abnormalities of platelet function
e) Abnormal or decreased platelet production
f) Increased peripheral platelet destruction (Table 66-2)
2) Evaluation and treatment
c) Medical diseases associated with bleeding abnormalities (Table 66-4)
ii) Blood tests of coagulation
(3) aPTT (activated partial thromboplastin time)
(4) PT, INR (prothrombin time, international normalized ratio)
(6) ACT (activated clotting time)
ii) Coagulation factor assays
iv) Factor inhibitor assay
v) Platelet function tests
vi) Assessment of platelet function
b) Intraoperative management
(c) Postoperative management
Part H: Skin and Musculoskeletal Diseases. Malignant Hyperthermia
B, later signs and symptoms
ii) Administer dantrolene
iv) Monitor and treat signs and symptoms
v) Maintenance of anesthesia
4) Future anesthetic care
Chapter summary for malignant hyperthermia
1) Classification of thermal burns
b) Superficial partial thickness
c) Deep partial thickness
6) Anesthetic considerations
c) Large-bore IVs or central lines are needed for fluid and blood intraoperative considerations.
ii) Nondepolarizing muscle relaxants
7) Postoperative concerns
Arthritis Jillian S. Vitter-Andrea J. Traynor
1) Rheumatoid arthritis (R A)
d) Anesthetic considerations
2) Ankylosing spondylitis
b) Anesthetic considerations
b) Anesthetic considerations
4) Anesthetic management considerations for patients with arthritis a) Preoperative considerations ,
v) Laboratory and other testing
b) Intraoperative considerations
ii) IV access and invasive monitors
v) Perioperative stress-dose steroids
REFERENCES Systemic Lupus Erythematosus M. G. Lemley
ii) Valvular abnormalities
REFERENCES Myasthenia Gravis and Myasthenic Syndrome
3) Clinical presentation and diagnosis
5) Differential diagnosis
6) Preoperative evaluation
Medication reconciliation
7) Intraoperative management
iii) Nondepolarizing N M Bs
vii) Interactions with A C h E inhibitor therapy
b) Monitoring with peripheral nerve stimulator
g) Avoid medications that can exacerbate MG.
8) Postoperative considerations
10) M C corresponds to M G F A class five
b) A C h E l considerations in pregnancy
Lambert-Eaton Myasthenic Syndrome (L E M S)
c) Associated with small-cell lung cancer, other tumors, and autoimmune diseases
REFERENCES Part I: Psychiatric Disease and Substance Abuse. Psychiatric Diseases and Electroconvulsive Therapy
(a) Selective serotonin reuptake inhibitors, S S R I s
(b) Tricyclic antidepressants, T C A s
(c) Monoamine oxidase inhibitors (M A O I s)
(d) Ketamine infusion therapy
2) Bipolar disorder (manic-depressive illness)
4) Electroconvulsive therapy (Table 72-2)
h) Description of ECT procedure
Physiologic responses to ECT
5) Anesthetic considerations with E C T
b) Intraoperative considerations
iv) Monitoring and equipment
(1) Anticholinergic agents
(c) Calcium channel antagonists
c) Postoperative concerns
REFERENCES Alcohol and Substance Abuse†
a) Effects on organ systems (see Table 73-1)
ii) Cardiovascular, C V, system
iv) Gastrointestinal and hepatobiliary systems
v) Fluid and electrolyte abnormalities
vii) Nutritional deficiencies
b) Effects on anesthetic agents
ii) Intravenous anesthetics
iv) Sympathomimetic medications
2) Cannabinoids (cannabis, marijuana, dope, grass, hash, pot, weed) a) General information
b) Effects on organ systems (Table 73-2)
c) Anesthetic considerations
ii) Intraoperative considerations
ii) Postoperative considerations
d) Dependency and withdrawal states
e) Synthetic cannabinoids (Incense, Spice, K2)
c) Effects on organ systems (Table 73-3)
d) Effects on organ systems (Table 73-4)
e) Anesthetizing the cocaine-intoxicated patient
ii) Intraoperative considerations
iii) Postoperative considerations
6) Phenylethylamines: Amphetamine and its derivatives (Methamphetamine, Crystal Meth, Ecstasy, MDMA
d) Effects on organ systems
e) Anesthetic considerations
7) Phencyclidine (PCP, angel dust)
8) Lysergic acid diethylamide (L S D), novel psychoactive substances (N P S), and other hallucinogens
Overview of Pediatric Anesthesiology
1) Anatomy and physiology
viii) Pediatric cuffed E T Ts
ix) Appropriate E T T depth
x) Single-lung ventilation
xi) Laryngeal mask airways (LMAs)
2) Preoperative evaluation
ii) Parental presence at induction, P P I
c) Congenital heart disease
e) Upper respiratory infection (URI)
3) Induction, maintenance, and emergence
(b) Skeletal muscle relaxation
f) Postoperative nausea and vomiting
REFERENCES 75 Practical Pediatric Anesthesia Michael Lennig, Ellen Choi, Calvin Kuan
Normal Pediatric Vital Signs (Table 75-1) Pediatric Airway
a) Endotracheal intubation (Table 75-2)
ix) Special anesthetic considerations:
2) Alternative airway equipment (Table 75-4)
b) Single-lung ventilation (Table 75-6):
1) Central venous catheter insertion
Hematologic Considerations in the Pediatric Patient (Tables 75-8 and 75-9)
Pharmacologic Considerations in the Pediatric Patient (Tables 75-10 and 75-11)
Ensuring Safety in the Pediatric Patient
2) Constant preparation for medication injection for unforeseen developments
REFERENCES Management of Pediatric Arrest and Resuscitation
1) Pediatric perioperative cardiac arrest
2) Circulation (Table 76-1)
b) Defibrillation—for pulseless ventricular tachycardia (VT) and ventricular fibrillation (VF)
c) Cardioversion—for atrial tachycardias, SVT, or symptomatic VT with pulse present
b) Endotracheal intubation
6) Postresuscitation management
7) Resuscitation in special scenarios
Pediatric Cardiac Arrest Algorithm—2015 Update Pediatric Bradycardia With a Pulse and Poor Perfusion Algorithm 1 Pediatric Tachycardia With a Pulse and Poor Perfusion Algorithm
References Ethical Considerations in Pediatric Anesthesiology
One) Anesthesiologists as moral agents
c) Respectful communication
3 Minors' human rights include the following
4) Pediatric developmental continuum (Table 77-1)
5) Important concepts in pediatric ethics
7) Consent and assent (Tables 77-1 and 77-2)
What is needed to provide assent?
c) Minors as decision makers
9) Unique parents and guardians
11) Refusal of treatment by minor patient
12) Pediatric limitations on life-sustaining therapy (Fig. 77-3)
13) Medically ineffective treatment
14) Jehovah's Witnesses and refusal of blood transfusions
f) When parents refuse to consent to blood transfusions for their child, there are several means to address this:
g) Adolescent Jehovah's Witnesses
15) Suspicion of child abuse 15
19) Labor epidurals in teens
20) Workplace safety and workplace violence
C) Reasons one might request an ethics consultation
REFERENCES Part A: Diseases in Pediatric Patients Congenital Diaphragmatic Hernia Sally Vender
2) Signs and symptoms/clinical findings
b) Preoperative studies and tests
d) Intraoperative management
ii) Anesthetic considerations
(2) Pulmonary/ventilation
REFERENCES Tracheoesophageal Fistula
1) Pathophysiology/anatomy
2) Signs/symptoms/clinical findings
c Intraoperative management
ii) Special anesthetic considerations
5) Postoperative management
b) Postoperative complications
REFERENCES 80 Myelomeningocele Debnath Chatterjee
b) S B occulta (Fig. 80-1)
c) S B cystica (Fig. 80-1)
d) Myelomeningocele (M M C) (Fig. 80-2)
2) Pathophysiology/embryology
3) Signs/symptoms/clinical findings
5) Anesthetic considerations
Chapter Summary for Myelomeningocele
References Patent Ductus Arteriosus
2) Signs, symptoms, clinical findings
c) Percutaneous intervention
c) Intraoperative management
d) Postoperative management
CHAPTER SUMMARY FOR P D A LIGATION
SUGGESTED READINGS Omphalocele and Gastroschisis
1) Pathophysiology/embryology
2) Signs, symptoms, clinical findings (Table 82-1)
c) Intraoperative management
two) Special anesthetic considerations
d) Postoperative management
2) Signs/symptoms/clinical findings
c) Intraoperative management
iii) Special anesthetic considerations
d) Postoperative management/analgesia
CHAPTER SUMMARY FOR INTUSSUSCEPTION
Hypertrophic Pyloric Stenosis
2) Signs/symptoms/clinical findings
b) Later: evidence of hypovolemia
c) Much later: severe dehydration
c) Intraoperative management
ii) Special anesthetic considerations
d) Postoperative management
3) Preoperative evaluation
b) Get accurate information
c) Past medical/surgical history
(2) Baseline platelet count
4) Special anesthetic considerations
c) Postoperative care/disposition
Glossary of Congenital Heart Disease Terms
Endocardial cushion defect, E C D, also known as A V canal, also known as atrioventricular septal defect
Children With Special Neurodevelopmental Needs
b) Stereotyped behavior, including:
c) Sensory processing difficulties
b) Aggression and self-injury
vii) Day of Procedure – Practical Steps
c) Intraoperative management
d) Postoperative management/disposition
2) Types of muscular dystrophy
b) Becker muscular dystrophy (B M D)
d) Emery-Dreifuss muscular dystrophy
3) Signs/symptoms/clinical findings
4) Anesthetic management for patients with DMD or BMD
b) Intraoperative management
c) Postoperative management
REFERENCES 88 Cystic Fibrosis Tammy Wang - Samuel A. Mireles
2) Surgeries/procedures commonly performed in CF patients
v) Pulmonary optimization
c) Intraoperative management
d) Postoperative management/disposition
REFERENCES Part B: Anesthetic Concerns and Procedures in Pediatric Anesthesia Anesthesia for the Premature Infant
1) Physiology and implications of prematurity
b) Central nervous system
ii) Cerebral autoregulation and complications
(f) Fluid, electrolytes and nutrition
h) Temperature regulation is important in small infants.
2) Preanesthetic evaluation
d) Postoperative management/disposition
4) Anesthesia and neurotoxicity
2) Signs, symptoms, clinical findings
b) Intraoperative considerations
(2) Controlled versus spontaneous ventilation
(b) Spontaneous ventilation
c) Special anesthetic considerations
vi) Acute postobstructive pulmonary edema
(c) Strategies to decrease the risk of airway obstruction
ii) Positioning patient for emergence
iii) Analgesic management
(6) Nonsteroidal anti-inflammatory drugs (N S A I Ds) should only be used after consulting with the surgeon.
5) Postoperative considerations
6) Posttonsillectomy bleeding is a surgical emergency (Fig. 90-1).
ii) Rapid-onset muscle relaxation is indicated.
i) Postoperative management/disposition
b) Monitors/lines/positioning
c Intraoperative management
iii) Special anesthetic considerations
d) Postoperative management
2) Signs/symptoms/clinical findings
c) Intraoperative management
ii) Special anesthetic considerations
iv) Special surgical considerations
d) Intraoperative complications
e) Postoperative management
2) Signs, symptoms, clinical findings
c) Intraoperative management
ii) Special anesthetic considerations
5) Postoperative management
Chapter summary for epiglottitis Congenital Syndromes and Anesthetic Implications
b) Anesthetic implications
b) Anesthetic implications
b) Anesthetic implications
b) Anesthetic implications
6) Beckwith-Wiedemann syndrome
b) Anesthetic implications
b) Anesthetic implications
b) Anesthetic implications
Crouzon syndrome [craniofacial dysostosis type I], Pfeiffer syndrome
b) Anesthetic implications
c) Preschool-age children often undergo maxillary advancement procedures (LeFort one, two, three osteotomies).
a) Essential characteristics
b) Anesthetic implications
11) Glycogen storage disease type I (von Gierke disease)
b) Anesthetic implications
12) Glycogen storage disease type II (Pompe disease)
b) Anesthetic implications
13) Glycogen storage disease type II (Cori disease/Forbes disease)
b) Anesthetic implications
14) Glycogen storage disease type IV (Andersen disease)
b) Anesthetic implications
15) Glycogen storage disease type V (McArdle disease)
b) Anesthetic implications
16) Hereditary angioedema
b) Anesthetic implications
b) Anesthetic implications
b) Anesthetic implications
b) Anesthetic implications
20) Kawasaki disease (mucocutaneous lymph node syndrome)
b) Anesthetic implications
21) Klippel-Feil syndrome
b) Anesthetic implications
22) Klippel-Trenaunay syndrome
b) Anesthetic implications
a) Essential characteristics
b) Anesthetic implications
24) Mitochondrial disease
b) Anesthetic implications
b) Anesthetic implications
b) Anesthetic implications
27) Nager syndrome (acrofacial dysostosis syndrome)
b) Anesthetic implications
28) Parkes-Weber syndrome
b) Anesthetic implications
29) Pierre Robin sequence
b) Anesthetic implications
30) Pseudohypoparathyroidism
b) Anesthetic implications
31) Shy-Drager syndrome (multiple system atrophy)
b) Anesthetic implications
b) Anesthetic implications
iv) Paramyotonia congenita
33) Smith-Lemli-Opitz syndrome
b) Anesthetic implications
34) Treacher-Collins syndrome (mandibulofacial dysostosis)
b) Anesthetic implications
35) Trisomy 21 (Down syndrome)
b) Anesthetic implications
b) Anesthetic implications
b) Anesthetic implications
38) von Hippel-Lindau disease
b) Anesthetic implications
39) von Willebrand disease and von Willebrand syndrome
b) Anesthetic implications
b) Anesthetic implications
References Caudal Epidural Anesthesia
3) Risks and complications
d) Clonidine (1 to 2 micrograms per kilogram)
e) Ketamine (0.5 milligrams per kilogram)
b) Positioning and preparation (Fig. 95-1)
c) Placement of block (Fig. 95-2)
8) Continuous epidural catheter
9) Anesthetic considerations
10) Evaluation of the block
11) Caudal and fistula after hypospadias repair
12) Postoperative management
CHAPTER SUMMARY FOR CAUDAL EPIDURAL ANESTHESIA
Management of the Pediatric Difficult Airway
2) Pediatric anatomy/physiology
3) Evaluation of pediatric airway
4) Basic guidelines for management of the pediatric difficult airway
d) Maintain spontaneous ventilation
e) Always have an LMA immediately available as backup.
g) Call for help early enough to make a difference!
6) Difficult airway algorithm
b) Unanticipated difficult airway
Failed airway (cannot intubate/cannot ventilate)
7) Special techniques/situations
b) Fiberoptic intubation of small child with adult bronchoscope
ii) Necessary additional equipment
c) Emergency needle cricothyrotomy)
Scalpel-Bougie technique for emergency front of neck access (F O N A), Chapter 166
i) Distorted or indistinguishable anatomy:
ii) Abdominal distention may impair ventilation.
Chapter summary for management of the pediatric difficult airway
References Mechanical circulatory support
1) Cardiopulmonary bypass
2) The cardiopulmonary bypass machine
3) Management of cardiopulmonary bypass
4) Anesthetic considerations
iv) Fluids and electrolytes
four) Oxygenation and ventilation
five) Fluids/electrolytes
Chapter summary for C P B
i) Modifiable risk factors
ii) Nonmodifiable risk factors
b) Atherosclerosis (Fig. 98-1)
c) Atherosclerotic plaque changes
3) Clinical syndromes of IHD
b) Myocardial infarction (M I)
(2) Subendocardial (nontransmural)
c) Sudden Cardiac Death (S C D)
d) Chronic I H D or ischemic cardiomyopathy
a) Contractile dysfunction
d) Right ventricular dysfunction
i) Papillary muscle dysfunction
7) Anesthetic considerations for the patient with C A D
ii) Physical examination (Table 98-2)
b) Intraoperative management
(5) Detection of ischemia
c) Induction and maintenance
d) Postoperative management
e) Postoperative ischemia
1) Normal mitral valve anatomy and function
ii) Biventricular dysfunction
d) Clinical presentation (Table 99-3)
e) Anesthetic considerations
(1) Heart rate and rhythm
(5) Pulmonary vascular resistance (P V R)
ii) Preoperative assessment
ii) Percutaneous mitral balloon commissurotomy
d) Clinical presentation (Table 99-3)
e) Anesthetic considerations
(5) Pulmonary vascular resistance
ii) Preoperative assessment
References Aortic Valvular Disease
iii) Decreased L V compliance/increased diastolic dysfunction
b) Intermediate and late stages
4) Classification and severity grading
6) Preoperative management
7) Intraoperative management
8) Postoperative management
9) Treatment of aortic stenosis
Aortic Regurgitation (AR)
Three, signs and symptoms.
(4) Classification and severity grading
(5) Preoperative risk stratification
(6) Preoperative management
(7) Intraoperative management
8) Postoperative management
9) Treatment of aortic regurgitation
iii) Surgical management:
Right Ventricle, Tricuspid Valve, and Pericardiectomy
1) Anatomy of the right heart
3) Pericarditis and pericardial disease
b) Incidence and prevalence of pericarditis
c) Signs and symptoms of pericardial disease
d) Therapy for pericarditis
4) Preoperative assessment for pericardiectomy
c Perioperative risk predictors
d) Functional studies for preoperative cardiac evaluation
e) Imaging studies for preoperative pericardial evaluation
5) Intraoperative concerns (Table 101-1)
ii) Left-sided anterolateral thoracotomy
iii) Bilateral anterior thoracotomy
v) Surgical approach considerations
d) Induction of anesthesia
e) Maintenance of anesthesia
f) Cardiopulmonary bypass
g) Intraoperative blood component therapy
h) Intraoperative T E E evaluation
i) Tricuspid regurgitation
6) Postoperative challenges
d) Arrhythmia and pacemaker support
e) Right ventricular failure
g) Pulmonary hypertension
REFERENCES Aortic Disease and Procedures
4) Types of aortic dissection
i) Peripheral cannulation
ii) Cardiopulmonary bypass (C P B)
iv) Deep hypothermic circulatory arrest
v) Selective cerebral perfusion
c) Retrograde cerebral perfusion
d) Selective antegrade cerebral perfusion
e) Pharmacologic neuroprotection
b) Symptoms may be present.
a) The Crawford classification is used.
c) Aortic root and valve involvement
REFERENCES Anesthesia for Minimally Invasive Cardiac Surgery
Section 1: Transcatheter Valve Therapies
ii) Indications for TAVR (Table 103-1)
b) Preoperative assessment
ii) Assess suitability for monitored anesthesia care (M A C) vs G A-based anesthetic. (Table 103-2)
(a) Procedural considerations
(b) Monitoring considerations
(c) Patient comorbidities
iv) Geriatric considerations
d) Intraoperative management
iii) Hemodynamic management
vi) Postoperative management
2) Non-aortic transcatheter valve therapies
b) Mitral valve therapies
Two) Transcatheter mitral valve replacement (T M V R)
c) Pulmonary valve replacement
Section 2: Endovascular Procedures of the Aorta
1) Endovascular abdominal aortic repair (E V R)
b) Abdominal aortic aneurysm (AAA) etiology and pathophysiology
c) AAA signs and symptoms
(e) EVAR procedural steps
(f) Preoperative considerations
g) Intraoperative management
ii) Considerations by organ system (Table 103-6)
2) Thoracic endovascular aortic repair (TEVAR)
b) Thoracoabdominal aortic disease etiology and pathophysiology
c) Thoracoabdominal aortic disease signs and symptoms
ii) Diagnosis of thoracoabdominal aortic disease
d) Thoracoabdominal aortic disease (T A A A) management
e) T E V A R procedural steps
f) Preoperative considerations
g) Intraoperative management
h) Postprocedure management
i) Spinal cord ischemia (S C I)
v) Postoperative hemodynamic goals and neurologic monitoring
References Heart, Lung, and Heart-Lung Transplantation
b) Preoperative considerations
ii) Preoperative assessment (Tables 104-2 to 104-4)
c) Intraoperative considerations for recipient i) Induction
ii) Pretransplant maintenance and management strategies
v) Posttransplant maintenance and management strategies (Table 104-5)
(2) Mechanical circulatory support:
d) Postoperative considerations
b) Preoperative considerations
iv) Preoperative checklist by systems (see Table 104-4)
c) Intraoperative considerations
ii) Pretransplant maintenance and management strategies
v) Posttransplant maintenance and management strategies
(d) Postoperative considerations
(3) Combined heart-lung transplantation
(b) Preoperative considerations
(c) Intraoperative considerations
(d) Postoperative considerations
Ventricular Assist Devices
One) General considerations
e) Continuous-flow devices
2) Preoperative considerations
3) Intraoperative considerations (Table 105-2)
4) Intraoperative complications (see Table 105-3)
Five. Postoperative considerations.
References. Perioperative transesophageal echo.
One. Perioperative management and guidance of cardiac surgery.
d) Congenital heart lesions
f) Minimally invasive procedures
g) Pericardial window procedures
b) Management of the ICU patient
c) Assessment of intracardiac masses and embolic sources
4) Risks and complications
d) Pulsed and continuous wave Doppler
g) Strain echocardiography